Your browser doesn't support javascript.
loading
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.
Dong, Xinyue; Ren, Jun; Amoozgar, Zohreh; Lee, Somin; Datta, Meenal; Roberge, Sylvie; Duquette, Mark; Fukumura, Dai; Jain, Rakesh K.
Afiliação
  • Dong X; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ren J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Amoozgar Z; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lee S; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Datta M; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Roberge S; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Duquette M; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Fukumura D; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Jain RK; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA jain@steele.mgh.harvard.edu.
J Immunother Cancer ; 11(3)2023 03.
Article em En | MEDLINE | ID: mdl-36898734
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article